http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
MacKay Municipal Managers Shares Top Five Municipal Market Predictions For 2026
-
Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER® Robotic Surgery System
-
David Ebrahimzadeh and Corniche Capital Advance Power-Enabled Data Center Developments in New Mexico and South Carolina
-
HII Expands European Unmanned Operations with New Facility in Portchester, UK
-
Clene secures FDA meeting to discuss ALS drug biomarker data
-
Clene Announces Additional CNM-Au8 Biomarker Data Supporting Potential NDA Filing for Upcoming In-Person FDA Meeting
-
Water Tower Research Highlights Ainos SmellTech's Rising Commercial Momentum in Scalable AI Infrastructure Platform Shift
-
NantWorks and ImmunityBio Announce Inaugural U.S.-Saudi Biotech Alliance Summit to Advance Immunotherapy 2.0 and Global Health Security
-
Cogent Biosciences outlines 2026 milestones for bezuclastinib drug applications
-
Avantor® to Report Fourth Quarter and Full Year 2025 Earnings on Wednesday, February 11, 2026
-
Praxis plans two drug applications by mid-February, raises $1.5 billion
-
Wealth Minerals announces $1 million private placement offering
-
KOAMTAC Introduces Magnetic Universal Adaptor (MUA) for Fast, Flexible SmartSled Integration
-
MDxHealth reports 21% revenue growth for 2025, issues 2026 guidance
-
Cardiovascular Logistics Appoints Nancy Probst as Vice President of Managed Care
-
ZAGG Honored with Consumer Electronics Industry Performance Award from Circana
-
Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference
-
PharmaEssentia Announces Positive Topline Phase 2b Data from EXCEED-ET Study Evaluating Ropeginterferon Alfa-2b-njft for Essential Thrombocythemia
-
Praxis Precision Medicines Enters Its Next Chapter Following a Pivotal Year of Progress
-
Cogent Biosciences Announces Anticipated 2026 Commercial and Clinical Milestones for Bezuclastinib and Precision Therapies Portfolio
-
Bojangles Brings its Iconic Southern Flavors and Fan-Favorite Chicken to New York with Brooklyn Opening
-
Ontario International Airport welcomes TSA acceptance of Digital IDs - a smarter, easier way to fly
-
Wealth Minerals Announces Private Placement
-
Bayer to Expand Into Molecular Imaging With Acquisition of Innovative Pan-Amyloid Radiotracers From Attralus
-
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences
-
EDM Announces Both Completion of 2025 Milestones and Its Operational, Permitting and Commercial Milestones for 2026
-
DeFi Technologies reports record $138M net inflows for Valour in 2025
-
NusaTrip partners with Bookcabin to expand in Indonesia travel market
-
AbbVie licenses cancer drug from RemeGen for $650 million upfront
-
Society Pass Incorporated, NusaTrip Incorporated and Bookcabin Announce Strategic Partnership to Expand Distribution in Projected US$115 Billion Indonesia Travel Market
-
DeFi Technologies Highlights Record Net Inflows at Valour in 2025, Underscoring Core Business Momentum Beyond AUM Price Volatility
-
Kobo Delivers Significant Progress at its Kossou Gold Project in 2025, Establishes a Scalable West African Gold Platform for 2026 and Hosted the 2nd Annual Kobo Cup
-
AbbVie and RemeGen Announce Exclusive Licensing Agreement to Develop A Novel Bispecific Antibody for Advanced Solid Tumors
-
Predictmedix AI Inc. Announces Proposed Name Change to QScreen AI Inc., Pioneering the Fusion of Quantum Computing and AI to Transform Healthcare
-
Scholar Rock targets 2026 apitegromab BLA resubmission and launch
-
Radiopharm Theranostics increases stake in cancer drug joint venture to 87.5%
-
NovoCure reports $655 million 2025 revenue, up 8% from prior year
-
Scholar Rock Highlights 2026 Strategic Priorities
-
Novocure Announces Preliminary Full Year and Fourth Quarter 2025 Performance and Provides Company Update
-
Ionis well-positioned for continued momentum and substantial value creation in 2026 with two new independent launches and several pivotal data readouts
-
RAD Increases Ownership in Radiopharm Ventures to 87.5%
-
MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference
-
Coppernico Defines 155 m of Continuous Copper Mineralization Averaging 0.54% at Sombrero’s Nioc Target
-
Aclaris starts phase 1b trial of ATI-052 for atopic dermatitis
-
Aclaris Therapeutics Initiates Phase 1b Proof-of-Concept Trial in Atopic Dermatitis (AD) with Its Novel Bispecific Antibody ATI-052
-
Supergasbras implements Descartes routing system for LPG operations
-
Supergasbras Modernizes Complex Gas Distribution Operations with Descartes Routing Solution
-
Kraken Robotics Hires Terra Penrose as Chief People Officer
-
APIA Scholars Releases FY2024-2025 Annual Report Highlighting Expanded Impact and College-to-Career Success
-
AbbVie to acquire West Pharmaceutical facility in Arizona for $175M
